Financial Sense Advisors’s Pfizer PFE Stock Holding History

Financial Sense Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Hold	–	-$689K	–	102
2023 Q1	–	Hold	–	–	–	68
2022 Q4	–	Hold	–	–	–	79
2022 Q3	–	Hold	–	–	–	68

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Financial Sense Advisors's PFE Position: Q4 2025 in Review

Financial Sense Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 46,305 shares — an estimated $1.18M sold.

Financial Sense Advisors first reported a position in PFE in Q2 2013 and held it in 34 quarters. The position peaked at $6.93M in Q1 2015. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Financial Sense Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Financial Sense Advisors sold 46,305 Pfizer shares in Q4 2025, an estimated $1.18M.
Financial Sense Advisors first reported a position in Pfizer in Q2 2013 and held it in 34 quarters.
Financial Sense Advisors's Pfizer position peaked at $6.93M in Q1 2015.
2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Financial Sense Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.